Related Experiment Video
Updated: Jan 31, 2026

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
Published on: November 14, 2016
Serum sTREM2 Levels and Disability Progression in Patients With Primary Progressive Multiple Sclerosis
Nicolás Fissolo1,2, Pascal Benkert3,4, Andreu Vilaseca-Jolonch1
1Servei de Neurologia, Centre D'esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall D'hebron (VHIR), Hospital Universitari Vall D'hebron. Universitat Autònoma de Barcelona, Barcelona, Spain.
Background:
Triggering receptor expressed on myeloid cells 2 (TREM2) is a microglia surface receptor that aids in tissue repair and debris clearance. The soluble form, sTREM2, found in both blood and cerebrospinal fluid, is considered a biomarker for microglial activation. Based on the central role of microglia in MS pathogenesis, we aimed to investigate whether serum sTREM2 levels could predict disability progression in patients with primary progressive MS.
Methods:
Serum levels of sTREM2 were measured at baseline using a single-molecule array assay in a multicenter cohort of 137 primary progressive multiple sclerosis (PPMS) patients. Univariable and multivariable linear models evaluated the association between sTREM2 levels and EDSS change at 2 years, 6 years, and last follow-up.
Results:
While an association was observed at 2 years only in non-inflammatory PPMS patients, no consistent relationship was found between sTREM2 levels and disability progression over longer follow-up.
Conclusions:
These findings suggest that serum sTREM2 may have limited value as a biomarker of disability progression in PPMS.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Intellectual Disability
Learning Disabilities
Dyslexia
Dyslexia is a...
Multiple Allele Traits
Leveling Effect

